FinnProstate Group
Open-knowledge reference entry
The FinnProstate Group (FP), or FinnProstate Study Group, is a group of scientific researchers in Finland who have conducted a series of clinical trials of treatments for prostate cancer. The first publication by the group was in 1985 and the latest publication was in 2019.
Clinical trials
The studies conducted by the FinnProstate group include the following:
FinnProstate-1 (FinnProstate-I; Finnish Multicentre Study of Prostatic Cancer) – ethinylestradiol 150 μg/day (1 mg/day initially) plus polyestradiol phosphate 80 mg/month (160 mg/month initially) versus orchiectomy for advanced prostate cancer
FinnProstate-2 (FinnProstate-II) – polyestradiol phosphate 160 mg/month (with or without low-dose aspirin) versus orchiectomy for advanced prostate cancer
FinnProstate-3 (FinnProstate-III) – cancelled
FinnProstate-4 (FinnProstate-IV) – polyestradiol phosphate 160 mg/month versus buserelin (with cyproterone acetate 300 mg/day initially to prevent gonadotropin flare) in advanced or metastatic prostate cancer
FinnProstate-5 (FinnProstate-V) – cancelled
FinnProstate-6 (FinnProstate-VI) – polyestradiol phosphate 240 month (320 mg/month initially) versus orchiectomy for advanced prostate cancer
FinnProstate-7 (FinnProstate-VII) – intermittent versus continuous androgen deprivation therapy for advanced prostate cancer
Other studies by the FinnProstate group
Related trials
A related study, by the Finnish Zoladex Multicentre Study Group, assessed polyestradiol phosphate versus goserelin for advanced prostate cancer. A British group also assessed polyestradiol phosphate 160 mg/month versus orchiectomy for advanced prostate cancer. The SPCG-5 trial assessed polyestradiol phosphate 240 mg/month versus combined androgen blockade (triptorelin or orchiectomy plus flutamide) for advanced prostate cancer.
“FinnProstate Group” enters the record as open-knowledge reference entry. Crown Archives preserves that source wording while asking what FinnProstate, Group and Open-knowledge can confirm, complicate or overturn.
Why this record matters
“FinnProstate Group” is worth following because a concise public description often conceals a longer documentary argument. Here, FinnProstate, Group and Open-knowledge provides the most credible route into that argument.
Named sources, stable identifiers and responsible institutions provide the strongest route from overview to verifiable evidence. The source revision retrieved here is dated Aug 25, 2025. The linked authority identifier is Q111952161. None of the 0 selected statements returned an explicit reference. The first chronological checks are 1985 and 2019.
Overview language is designed for orientation and should not be treated as a substitute for the evidence cited beneath it. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “FinnProstate Group”, its source revision and the description used here.
- Expand the search: follow FinnProstate Group primary sources, FinnProstate Group archive and FinnProstate research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “FinnProstate Group”?
- Which cited source is closest to the event, object or claim?
- Which institution is responsible for the underlying evidence?
Search terms from this dossier
This entry incorporates text from “FinnProstate Group” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.